Profiling Pretomanid as a Therapeutic Option for TB Infection: Evidence to Date

Tuberculosis (TB) is the most deadly infectious disease globally. Although most individuals achieve a cure, a substantial portion develop multi-drug resistant TB which is exceedingly difficult to treat, and the number of effective agents is dwindling. Development of new anti-tubercular medications i...

Descripción completa

Detalles Bibliográficos
Autores principales: Stancil, Stephani L, Mirzayev, Fuad, Abdel-Rahman, Susan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253981/
https://www.ncbi.nlm.nih.gov/pubmed/34234413
http://dx.doi.org/10.2147/DDDT.S281639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253981/
https://www.ncbi.nlm.nih.gov/pubmed/34234413
http://dx.doi.org/10.2147/DDDT.S281639

Ejemplares similares